Home >
Corporate Governance - Committee Composition
Print print this page

Corporate Governance - Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Chairperson Chairperson Committee Member Member Financial Expert Financial Expert
 Audit CommitteeCompensation CommitteeNominating and Corporate Governance Committee
Steve R. Carchedi 
Biography PhotoSteve R. Carchedi
Director


Currently, Mr. Carchedi serves as the Senior Vice President and President, Commercial Operations (North America) for Mallinckrodt Pharmaceuticals. Having held key positions at several leading multinational pharmaceutical companies, Mr. Carchedi brings more than 30 years of commercial industry experience focused in Oncology, Neurology, Urology, Endocrinology and Cardiology. In addition to his industry experience, Mr. Carchedi currently serves on the Board of Directors of BioNumerick Pharmaceutic... 
  Committee Member  
Matthew K. Fust 
Biography PhotoMatthew K. Fust
Director


Matthew Fust has served as a member of our board of directors since 2005. Mr. Fust was the Chief Financial Officer of Onyx Pharmaceuticals, Inc. From 2008 to 2014 he was Chief Financial Officer of Jazz Pharmaceuticals, Inc., and from May 2002 to May 2003 Mr. Fust was Chief Financial Officer at Perlegen Sciences, Inc., a biotechnology company. From June 1996 to January 2002, he was an executive with ALZA Corporation, first as Controller and then as Chief Financial Officer. Mr. Fust holds a B.A. i... 
Chairperson Committee Member  
Helen Kim 
Biography PhotoHelen Kim
Director


Ms. Kim is currently the Interim Chief Executive Officer of privately held Cyterix Pharmaceuticals, Inc. She also serves as a Director of ImmunoCellular Therapeutics, Forsight VISION 4, and as a Strategic Advisor to NGM Biopharmaceuticals, Inc., where she had served as Chief Business Officer. Previously, she served as a Director and Chief Executive Officer of privately held TRF Pharma, Inc. She was the Chief Executive Officer and President of Kosan Biosciences Incorporated where she restructur... 
Committee Member   
Dayton Misfeldt 
Biography PhotoDayton Misfeldt
Director


Dayton Misfeldt has served as a member of our board of directors since April 2009. Mr. Misfeldt is an Investment Partner at Bay City Capital LLC and focuses on biopharmaceutical investment opportunities. Prior to joining Bay City Capital in May 2000, Mr. Misfeldt was a Vice President at Roth Capital Partners where he worked as a sell-side analyst covering the biopharmaceutical industry. Mr. Misfeldt has also worked as a Project Manager at Life Science Economics. Mr. Misfeldt received a B.A. in E... 
  Chairperson Committee Member
Homer L. Pearce, Ph.D. 
Biography PhotoHomer L. Pearce, Ph.D.
Director


Dr. Pearce has served as a member of our board of directors since June 2006. Dr. Pearce served in various capacities at Eli Lilly & Company since joining the company in 1979, including Vice President, Cancer Research and Clinical Investigation from 1994 to 2002 and Fellow, Cancer Research, Lilly Research Laboratories from 2002 to March 2006. Since August 2006, Dr. Pearce has served as a consultant to our company. He is a member of the American Association for Cancer Research, the American Chemic... 
   Chairperson
David C. Stump, M.D. 
Biography PhotoDavid C. Stump, M.D.
Director


Dr. Stump has served as a member of our board of directors since June 2006. He was most recently Executive Vice President, Research and Development at Human Genome Sciences, Inc., serving there from November 1999 until December 2012. Prior to joining Human Genome Sciences, Dr. Stump held roles of increasing responsibility at Genentech, Inc., from 1989 to 1999, most recently as Vice President, Clinical Research, and was named a Genentech Fellow in 1996. Prior to joining Genentech, Dr. Stump was a... 
Committee Member   
callout title graphic
Sunesis is a biopharmaceutical company focused on new oncology therapeutics for the treatment of solid and hematologic cancers.
Recent Webcasts
Listen to recent webcasts of presentation conference calls, earnings calls, and more.